Riskpilot← Back to searchSign inGet full accessNYSOM AB
ABDissolvedOrg 5590624283Engineering activities and related technical consultancy · NACE 7112Est. 20160 employees
Revenue 2021
SEK 0
EBITDA margin
—
-103% vs 2020
Equity ratio
100.0%
Financial strength
Net profit 2021
SEK -1K
-104% vs 2020
| Revenue | SEK 0 | — |
| EBITDA | SEK -1K | -103% |
| Net profit | SEK -1K | -104% |
| Total assets | SEK 49K | -41% |
| Equity | SEK 49K | -34% |
| Employees | 0 | — |
Legal name
NYSOM AB
Org number
5590624283
Legal form
Aktiebolag
NACE code
7112 · Engineering activities and related technical consultancy
Founded
12 maj 2016
Share capital
SEK 0
Employees
0
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanterna
Company purpose
Aktiebolaget skall bedriva konsult- och utbildningsverksamhet inom området in vitro diagnostik och därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Revenue | 273 | 213 | 116 | 33 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 242 | 210 | 100 | 31 | −1 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 242 | 210 | 100 | 31 | −1 |
| Net financials | — | — | — | — | — |
| Profit before tax | 241 | 210 | 99 | 31 | −1 |
| Tax | −53 | −46 | −21 | −7 | −0 |
| Net profit | 188 | 164 | 78 | 24 | −1 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Total assets | 374 | 331 | 166 | 83 | 49 |
| Equity | 239 | 214 | 128 | 74 | 49 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 135 | 117 | 38 | 8 | 0 |
| Total debt | 135 | 117 | 38 | 8 | — |
EBITDA margin
-100000.0%
This company
15.8%
Market median
-633011% vs market
20172021
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20172021
Return on equity
-2.0%
This company
18.4%
Market median
-111% vs market
20172021
Net profit margin
-100000.0%
This company
8.1%
Market median
-1234668% vs market
20172021
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20172021
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20172021
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Former (3) | ||
| Deputy Board Member | 2022 – 2022 | |
| Board of Directors | 2022 – 2022 | |
| Deputy Board Member | 2022 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of NYSOM AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Leif Gustav Andersson | Deputy Board Member | 0 companies |
| Inger Margareta Dahle | Deputy Board Member | 0 companies |
| Barbro Elisabeth Hansson | Deputy Board Member | 0 companies |
| Bengt Junior Niklas Nygårds | Board of Directors | 0 companies |
| Nils Yngve Ragnar Sommarin | Board of Directors | 0 companies |
| Annika Lise-Lotte Sommarin | Deputy Board Member | 0 companies |
| Ulrika Margareta Ahlholm | Deputy Board Member | 0 companies |